BR9714299A - Composto macromolecular, processos para detecção de virus da influenza e tratamento de infeção da influenza, composição farmacêutica para esse tratamento e utilização de composto - Google Patents

Composto macromolecular, processos para detecção de virus da influenza e tratamento de infeção da influenza, composição farmacêutica para esse tratamento e utilização de composto

Info

Publication number
BR9714299A
BR9714299A BR9714299-9A BR9714299A BR9714299A BR 9714299 A BR9714299 A BR 9714299A BR 9714299 A BR9714299 A BR 9714299A BR 9714299 A BR9714299 A BR 9714299A
Authority
BR
Brazil
Prior art keywords
treatment
compound
processes
influenza
detection
Prior art date
Application number
BR9714299-9A
Other languages
English (en)
Inventor
Phillip A Reece
Keith Geoffrey Watson
Wen-Yang Wu
Betty Jin
Original Assignee
Biota Scient Mangent Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO3632A external-priority patent/AUPO363296A0/en
Priority claimed from AUPO8539A external-priority patent/AUPO853997A0/en
Application filed by Biota Scient Mangent Pty Ltd filed Critical Biota Scient Mangent Pty Ltd
Publication of BR9714299A publication Critical patent/BR9714299A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

<B><MU>COMPOSTO MACROMOLECULAR, PROCESSOS PARA DETECçãO DE VìRUS DA INFLUENZA E TRATAMENTO DE INFECçãO DA INFLUENZA, COMPOSIçãO FARMACêUTICA PARA ESSE TRATAMENTO E UTILIZAçãO DE COMPOSTO<MV><D>. A invenção proporciona novas macromoléculas, processos para a sua preparação, suas formulações farmacêuticas e sua utilização como agentes contra influenza. A invenção também propociona um novo processo de diagnóstico que pode ser usado para detecção de todos os tipos de vírus de influenza A e B. O composto macromolecular da invenção tem fixadas a ele uma ou mais moléculas (aglutinantes de neuraminidase) que se ligam ao local de neuraminidase de vírus da influenza ativo, mas que não são divididos pela neuraminidase.
BR9714299-9A 1996-11-14 1997-11-13 Composto macromolecular, processos para detecção de virus da influenza e tratamento de infeção da influenza, composição farmacêutica para esse tratamento e utilização de composto BR9714299A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO3632A AUPO363296A0 (en) 1996-11-14 1996-11-14 Method and novel compounds for use therein
AUPO8539A AUPO853997A0 (en) 1997-08-14 1997-08-14 Method and novel compounds for use therein
PCT/AU1997/000771 WO1998021243A1 (en) 1996-11-14 1997-11-13 Method and novel compounds for use therein

Publications (1)

Publication Number Publication Date
BR9714299A true BR9714299A (pt) 2000-04-25

Family

ID=25645315

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9714299-9A BR9714299A (pt) 1996-11-14 1997-11-13 Composto macromolecular, processos para detecção de virus da influenza e tratamento de infeção da influenza, composição farmacêutica para esse tratamento e utilização de composto

Country Status (19)

Country Link
US (1) US6680054B1 (pt)
EP (1) EP0951480A4 (pt)
JP (1) JP3691075B2 (pt)
KR (1) KR20000068986A (pt)
CN (1) CN1238783A (pt)
AP (1) AP9901531A0 (pt)
AU (1) AU732916C (pt)
BR (1) BR9714299A (pt)
CA (1) CA2271249C (pt)
CZ (1) CZ167999A3 (pt)
EA (1) EA001603B1 (pt)
HU (1) HUP9904009A3 (pt)
IL (1) IL129762A0 (pt)
IS (1) IS5044A (pt)
NO (1) NO992297L (pt)
NZ (1) NZ335368A (pt)
PL (1) PL333364A1 (pt)
TR (1) TR199901081T2 (pt)
WO (1) WO1998021243A1 (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US7425541B2 (en) * 1998-12-11 2008-09-16 Medarex, Inc. Enzyme-cleavable prodrug compounds
AUPP913999A0 (en) 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AUPR001000A0 (en) * 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US20030068655A1 (en) * 2001-09-12 2003-04-10 Protiveris, Inc. Microcantilever apparatus and methods for detection of enzymes
AUPR879401A0 (en) 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
EP1853634B1 (en) * 2005-02-23 2016-08-10 Lipoxen Technologies Limited Activated sialic acid derivatives for protein derivatisation and conjugation
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
EA017957B1 (ru) * 2007-06-25 2013-04-30 Дзе Администрейторс Оф Дзе Тьюлейн Эдьюкейшнл Фанд Композиции и способы, ингибирующие грипп
AU2008272854B2 (en) * 2007-07-03 2014-03-13 Children's Hospital & Research Center At Oakland Inhibitors of polysialic acid de-N-acetylase and methods for using the same
JP5523313B2 (ja) 2007-07-03 2014-06-18 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド ポリシアル酸誘導体、製造方法、ならびにがん抗原産生の増強およびターゲティングにおける使用
JP5702600B2 (ja) 2007-07-03 2015-04-15 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド オリゴシアル酸誘導体、製造方法および免疫学的使用
US20130280204A1 (en) * 2007-08-27 2013-10-24 Massachusetts Institute Of Technology Polymer-Attached Inhibitors of Influenza Virus
US20090076133A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched zanamivir
US8680020B2 (en) 2008-07-15 2014-03-25 Academia Sinica Glycan arrays on PTFE-like aluminum coated glass slides and related methods
AU2010247141A1 (en) 2009-05-15 2011-12-15 Redx Pharma Plc Redox drug derivatives
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
PL225045B1 (pl) 2012-05-18 2017-02-28 Univ Jagielloński Zastosowanie polimeru chitozanowego do wytwarzania leków do leczenia i profilaktyki infekcji wywołanych przez koronawirusy
AU2013306098A1 (en) 2012-08-18 2015-02-12 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
WO2014152946A2 (en) 2013-03-14 2014-09-25 University Of Washington Through Its Center For Commercialization Polypeptides for treating and/or limiting influenza infection
CN105264086B (zh) 2013-04-01 2018-06-15 贝克顿·迪金森公司 用于流感诊断的方法和试剂盒
US10086054B2 (en) 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
US9981030B2 (en) 2013-06-27 2018-05-29 Academia Sinica Glycan conjugates and use thereof
EP3041484B1 (en) 2013-09-06 2021-03-03 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
AU2015206370A1 (en) 2014-01-16 2016-07-07 Academia Sinica Compositions and methods for treatment and detection of cancers
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
TWI687428B (zh) 2014-03-27 2020-03-11 中央研究院 反應性標記化合物及其用途
KR102576850B1 (ko) 2014-05-27 2023-09-11 아카데미아 시니카 박테로이드 기원의 푸코시다제 및 이의 사용 방법
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
US10005847B2 (en) 2014-05-27 2018-06-26 Academia Sinica Anti-HER2 glycoantibodies and uses thereof
KR20170003720A (ko) 2014-05-27 2017-01-09 아카데미아 시니카 항-ｃｄ20 글리코항체 및 이의 용도
CA2950433A1 (en) 2014-05-28 2015-12-03 Academia Sinica Anti-tnf-alpha glycoantibodies and uses thereof
JP6899321B2 (ja) 2014-09-08 2021-07-07 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 糖脂質を使用するヒトｉＮＫＴ細胞活性化
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
AU2015378564A1 (en) 2015-01-24 2017-07-13 Academia Sinica Novel glycan conjugates and methods of use thereof
CA3005774C (en) 2015-11-20 2024-01-09 Australian Biomedical Co. Pty Ltd Compounds and methods for the treatment and/or prevention of influenza infection
TW201808978A (zh) 2016-03-08 2018-03-16 中央研究院 N-聚醣及其陣列之模組化合成方法
CN109963868B (zh) 2016-08-22 2023-11-14 醣基生医股份有限公司 抗体、结合片段及使用方法
JP2021536483A (ja) 2018-09-06 2021-12-27 シダラ セラピューティクス インコーポレーテッド ウイルス感染症の治療のための組成物及び方法
TW202122117A (zh) 2019-09-06 2021-06-16 美商席達拉醫療有限公司 用於治療病毒感染之組合物及方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ288492B6 (en) 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
US5221611A (en) 1991-06-19 1993-06-22 Sigma Chemical Company Ddi immunoassays, derivatives, conjugates and antibodies
AU659501B2 (en) * 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
WO1994011005A1 (en) * 1992-11-09 1994-05-26 Scientific Dimensions Usa, Inc. Viral attachment inhibitors
US5681811A (en) 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
GB9410817D0 (en) 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
HU228450B1 (en) * 1995-02-27 2013-03-28 Gilead Sciences Inc Novel selective inhibitors of viral or bacterial neuraminidases
GB9516276D0 (en) 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
DE69721242T2 (de) 1996-03-01 2004-01-29 Biota Scient Management Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen
AUPO104396A0 (en) 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Antiviral linear polymers
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use

Also Published As

Publication number Publication date
EP0951480A4 (en) 2004-07-28
EA001603B1 (ru) 2001-06-25
CA2271249A1 (en) 1998-05-22
HUP9904009A3 (en) 2001-07-30
JP3691075B2 (ja) 2005-08-31
KR20000068986A (ko) 2000-11-25
CZ167999A3 (cs) 1999-10-13
CA2271249C (en) 2010-07-20
WO1998021243A1 (en) 1998-05-22
US6680054B1 (en) 2004-01-20
NO992297D0 (no) 1999-05-12
AP9901531A0 (en) 1999-05-13
AU732916C (en) 2002-06-06
HUP9904009A2 (hu) 2000-03-28
EP0951480A1 (en) 1999-10-27
IL129762A0 (en) 2000-02-29
NZ335368A (en) 2001-08-31
TR199901081T2 (xx) 1999-08-23
JP2001504876A (ja) 2001-04-10
PL333364A1 (en) 1999-12-06
EA199900459A1 (ru) 1999-12-29
AU4857697A (en) 1998-06-03
CN1238783A (zh) 1999-12-15
NO992297L (no) 1999-07-12
AU732916B2 (en) 2001-05-03
IS5044A (is) 1999-04-30

Similar Documents

Publication Publication Date Title
BR9714299A (pt) Composto macromolecular, processos para detecção de virus da influenza e tratamento de infeção da influenza, composição farmacêutica para esse tratamento e utilização de composto
Kampf Efficacy of ethanol against viruses in hand disinfection
Eggers et al. Povidone-iodine hand wash and hand rub products demonstrated excellent in vitro virucidal efficacy against Ebola virus and modified vaccinia virus Ankara, the new European test virus for enveloped viruses
BR0113755A (pt) Composto multimérico, processo para a preparação de composto, composição farmacêutica que compreende o composto, processo para o tratamento e/ou profilaxia e detecção de uma infecção por virus, utilização do composto, e inalador que contém a composição
EA199901031A1 (ru) Производные бензимидазола
BRPI0413490A (pt) novos compostos
NO984004L (no) FremgangsmÕte for pÕvisning av influensavirus og forbindelser for anvendelse ved fremgangsmÕten
NL300364I2 (nl) Geïnactiveerd split influenzavirus van influenzastam A/California/7/2009 (H1N1) (X-179A), desgewenst van een pandemische influenzastam in een officieel verklaarde pandemische situatie
DE69818707D1 (de) Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa
BR9912653A (pt) Vìrus de herpes atenuado, cepa de vìrus, célula dendrìtica, processo para produzir um célula, composição farmacêutica, uso de um vìrus, e, processo para executar a terapia de gene em um paciente humano ou animal ou para tratar ou prevenir uma infecção patogênica ou câncer para tratar paciente animal
NO963499L (no) Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav
BR0309546A (pt) Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii
BR9813651A (pt) Compostos antipicornavirais e métodos para o seu uso e preparação
PT933993E (pt) Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase
BR0313060A (pt) Composições farmacêuticas aquosas de 2,6-diisopropilfenol
BR9810197A (pt) Produto, compostos, processo de preparação destes, composição farmacêutica, e, utilização de um produto
PT915707E (pt) Composicao farmaceutica que compreende um constituinte amiloide p de soro e que se destina ao tratamento profilatico ou terapeutico de infeccoes virais e estojo para a deteccao da fixacao de composicoes aos componentes de virus
Hosseini et al. Anti-influenza activity of a novel polyoxometalate derivative (POM-4960)
BR0317544A (pt) Uso de uma composição que compreende vlps de hpv 16 e hpv 18, e, métodos para induzir uma resposta imune contra um ou mais do grupo de tipos de hpv oncogênicos, para prevenir infecção e/ou doença causada por um ou mais do grupo de tipos de hpv oncogênicos, para prevenir a infecção de uma população de pacientes por um ou mais tipos de hpv, uso de uma mistura de vlps de hpv 16 e hpv18, e, composição de vacina
BR9805031A (pt) Compostos de naftaleno, processo para sua preparação e composições farmacêuticas contendo os mesmos.
WO1999062459A3 (en) Agents and methods for protection, treatment and repair of connective tissue
PT1194415E (pt) Novos derivados da piperazinil-alquil-tiopirimidina composicoes farmaceuticas que os contem e um processo de preparacao da substancia activa
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
BR9609416A (pt) Agentes antivìrus.
HUP0101224A2 (hu) Neuraminidáz inhibitor hatású pirrolidinszármazékok és ezeket a vegyületeket tartalmazó gyógyászati készítmények

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11 E 37 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: C07K 14/765; C07K 16/06; C07K 14/77; C08B 37/02; C12Q 1/70; C08G 69/48; C08F 8/32; G01N 33/569; A61K 38/38; A61K 31/785; A61K 31/73.

Ipc: G01N 33/569 (2006.01), C08B 37/02 (2006.01), C08F

Ipc: G01N 33/569 (2006.01), C08B 37/02 (2006.01), C08F